X0306 4 2018-10-22 0 0001169245 PhaseBio Pharmaceuticals Inc PHAS 0001452907 NEW ENTERPRISE ASSOCIATES 13 LP 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 0 0 1 0 0001460752 NEA Partners 13, Limited Partnership 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 0 0 1 0 0001460751 NEA 13 GP, Ltd 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 0 0 1 0 0001219855 BARRETT M JAMES 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 0 0 1 0 0001005561 BARRIS PETER J 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 0 0 1 0 0001277631 BASKETT FOREST 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 0 0 1 0 0001235112 KERINS PATRICK J 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 0 0 1 0 0001219871 MOTT DAVID M 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 0 0 1 0 0001237289 SANDELL SCOTT D 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 0 0 1 0 0001479386 Viswanathan Ravi 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 0 0 1 0 Common Stock 2018-10-22 4 C 0 4841634 A 4841634 I See Note 2 Common Stock 2018-10-22 4 P 0 1800000 5.00 A 6641634 I See Note 2 Warrants to Purchase Series B Preferred Stock 0.12 2018-10-22 4 X 0 49030 0.00 D Series B Preferred Stock 49030 0 I See Note 2 Series B Preferred Stock 2018-10-22 4 X 0 49030 0.12 A Common Stock 49030 3280804 I See Note 2 Series B Preferred Stock 2018-10-22 4 S 0 1177 5.00 D Common Stock 1177 3279627 I See Note 2 Series B Preferred Stock 2018-10-22 4 C 0 3279627 0.00 D Common Stock 3279627 0 I See Note 2 Warrants to Purchase Series C-1 Preferred Stock 0.12 2018-10-22 4 X 0 181190 0.00 D Series C-1 Preferred Stock 181190 0 I See Note 2 Series C-1 Preferred Stock 2018-10-22 4 X 0 181190 0.12 A Common Stock 181190 442055 I See Note 2 Series C-1 Preferred Stock 2018-10-22 4 S 0 4349 5.00 D Common Stock 4349 437706 I See Note 2 Series C-1 Preferred Stock 2018-10-22 4 C 0 437706 0.00 D Common Stock 437706 0 I See Note 2 Series D Preferred Stock 2018-10-22 4 C 0 1124301 0.00 D Common Stock 1124301 0 I See Note 2 Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date. The securities are directly held by New Enterprise Associates 13, L.P. ("NEA 13") and are indirectly held by NEA Partners 13, L.P. ("NEA Partners 13"), the sole general partner of NEA 13, NEA 13 GP, LTD ("NEA 13 LTD"), the sole general partner of NEA Partners 13 and each of the individual directors of NEA 13 LTD (NEA Partners 13, NEA 13 LTD and the individual directors of NEA 13 LTD (collectively, the "Directors") together, the "Indirect Reporting Persons"). The Directors of NEA 13 LTD are M. James Barrett, Peter J. Barris, Forest Baskett, Patrick J. Kerins, David M. Mott, Scott D. Sandell and Ravi Viswanathan. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 13 securities in which the Indirect Reporting Persons have no pecuniary interest. Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering. The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering. /s/ Sasha Keough, attorney-in-fact 2018-10-24